Evidence map›Paper›PMID 31053741›Full record

ArticleScientific reports2019

Avenanthramide C from germinated oats exhibits anti-allergic inflammatory effects in mast cells.

Hima Dhakal, Eun-Ju Yang, Soyoung Lee, Min-Jong Kim, Moon-Chang Baek, Byungheon Lee, Pil-Hoon Park, Taeg Kyu Kwon, Dongwoo Khang, Kyung-Sik Song and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Modulation of Mast Cell Activation via MRGPRX2 by Natural Oat Extract.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Ethanol Extract ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  10. Metabolite Profiling ofNutrients · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A Review of Health-Beneficial Properties of Oats.Foods (Basel, Switzerland) · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Hima DhakalCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Eun-Ju YangResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Soyoung LeeImmunoregulatory Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea.
Min-Jong KimDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Moon-Chang BaekDepartment of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Byungheon LeeDepartment of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Pil-Hoon ParkCollege of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Taeg Kyu KwonDepartment of Immunology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
Dongwoo KhangDepartment of Physiology, School of Medicine, Gachon University, Incheon, Republic of Korea. dkhang@gachon.ac.kr.ORCID http://orcid.org/0000-0003-4994-2966
Kyung-Sik SongResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea. kssong@knu.ac.kr.
Sang-Hyun KimCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. shkim72@knu.ac.kr.
Kyungpook National University · KRGachon University · KRKeimyung University · KRKorea Research Institute of Bioscience and Biotechnology · KRYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells play a crucial role in allergic diseases via the release of inflammatory mediators, particularly histamine and pro-inflammatory cytokines. Avenanthramide (Avn) C, a polyphenol found mainly in oats, is known to exhibit various biological properties. In this study, we aimed to evaluate the effectiveness of Avn C from germinated oats against mast cell-mediated allergic inflammation. For the in vitro study, RBL-2H3, mouse bone marrow-derived mast cells and rat peritoneal mast cells were used. Avn C (1-100 nM) inhibited the immunoglobulin (Ig)E-stimulated mast cells degranulation by suppressing phosphorylation of phosphoinositide 3-kinase and phospholipase Cγ1 and decreasing intracellular calcium levels. It inhibited IgE-stimulated secretion of inflammatory cytokines via suppression of FcεRI-mediated signaling proteins Lyn, Syk, Akt, and nuclear factor-κB. To verify the effects of Avn C in vivo, ovalbumin-induced active systemic anaphylaxis (ASA) and IgE-mediated passive cutaneous anaphylaxis (PCA) models were used. Oral administration of Avn C dose-dependently attenuated the ASA reactions, as evidenced by the inhibition of hypothermia and reduction of elevated serum histamine, IgE, and interleukin-4 levels. Avn C also inhibited the PCA reactions, such as ear swelling and plasma extravasation. Our results suggested that Avn C from germinated oats might be a possible therapeutic candidate for mast cell-mediated allergic inflammation.

Indexed as

GerminationAnimalsAnti-Allergic AgentsAnti-Inflammatory AgentsAvenaCell DegranulationCytokinesMaleMast CellsMiceMice, Inbred ICRortho-AminobenzoatesAnti-Allergic AgentsAnti-Inflammatory Agentsavenanthramide-2CCytokinesortho-Aminobenzoates

Identifiers

PMID31053741
PMCPMC6499795
OpenAlexW2943272945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.